GSK3 signaling in neural development

By E. Hur, Feng-Quan Zhou. Nature Reviews Neuroscience, 2010

828 citations recorded by the source corpus.

Recent evidence suggests that glycogen synthase kinase 3 (GSK3) proteins and their upstream and downstream regulators have key roles in many fundamental processes during neurodevelopment. Disruption of GSK3 signalling adversely affects brain development and is associated with several neurodevelopmental disorders. Here, we discuss the mechanisms by which GSK3 activity is regulated in the nervous system and provide an overview of the recent advances in the understanding of how GSK3 signalling controls neurogenesis, neuronal polarization and axon growth during brain development. These recent advances suggest that GSK3 is a crucial node that mediates various cellular processes that are controlled by multiple signalling molecules — for example, disrupted in schizophrenia 1 (DISC1), partitioning defective homologue 3 (PAR3), PAR6 and Wnt proteins — that regulate neurodevelopment.

Subfields: Genetics, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/45fcf53b460ec21082f343f7ff8cc345c2f4c2ad

Citations in the corpus

• The many faces and functions of β‐catenin (2012, neutral): “This mutual exclusivity is certainly valid for the key b -catenin interacting molecules: E-cadherin (the main partner in adherens junctions), APC (the main partner in the destruction complex), and TCF/Lef (the main partner in the nucleus).”